Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Estradiol Reprograms Microglia to Create an Immune-Suppressed Niche Permissive to Breast Cancer Brain Metastasis.
Journal: bioRxiv : the preprint server for biology
Published: May 13, 2026
Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.
Journal: JMIR research protocols
Published: February 03, 2026
Corrigendum to "Obesity-driven changes in breast extracellular matrix exhibit a pro-angiogenic phenotype" [Matrix Biol. Plus 24 (2024) 100162].
Journal: Matrix biology plus
Published: December 22, 2025
Exercise to Mitigate Premature Vascular Aging After Doxorubicin Breast Cancer Therapy.
Journal: Exercise and sport sciences reviews
Published: September 24, 2025
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of ER+ breast cancer brain metastases in young and aged hosts.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases.
Journal: Nature communications
Published: June 26, 2025
Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: April 28, 2025
Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 04, 2025
Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy.
Journal: The Lancet. Oncology
Published: April 03, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 25, 2025
Maf1 Cooperates with Progesterone Receptor to Repress RNA Polymerase III Transcription of Select tRNAs.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2025
Last Updated: 09/26/2026